|
China Tradicional Chinese Medicine Holdings Co. Limited (0570.hk) Avaliação DCF
HK | Healthcare | Drug Manufacturers - Specialty & Generic | HKSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
China Traditional Chinese Medicine Holdings Co. Limited (0570.HK) Bundle
Obtenha informações sobre sua análise de avaliação tradicional da China Chinese Medicine Holdings Co. Limited (0570HK) usando nossa calculadora DCF de última geração! Pré -carregado com dados reais (0570HK), este modelo do Excel o capacita a ajustar as previsões e suposições, permitindo que você determine o valor intrínseco da China Tradicional Chinese Medicine Holdings Co. Limitada com precisão.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15,295.9 | 15,814.2 | 20,349.9 | 15,278.1 | 19,355.6 | 20,992.8 | 22,768.6 | 24,694.5 | 26,783.4 | 29,049.0 |
| Revenue Growth, % | 0 | 3.39 | 28.68 | -24.92 | 26.69 | 8.46 | 8.46 | 8.46 | 8.46 | 8.46 |
| EBITDA | 3,253.9 | 3,373.9 | 3,836.4 | 2,307.3 | 2,730.9 | 3,806.9 | 4,128.9 | 4,478.2 | 4,857.0 | 5,267.8 |
| EBITDA, % | 21.27 | 21.33 | 18.85 | 15.1 | 14.11 | 18.13 | 18.13 | 18.13 | 18.13 | 18.13 |
| Depreciation | 631.0 | 730.7 | 907.4 | 1,174.2 | 1,210.4 | 1,139.7 | 1,236.1 | 1,340.6 | 1,454.0 | 1,577.0 |
| Depreciation, % | 4.13 | 4.62 | 4.46 | 7.69 | 6.25 | 5.43 | 5.43 | 5.43 | 5.43 | 5.43 |
| EBIT | 2,622.8 | 2,643.2 | 2,929.0 | 1,133.0 | 1,520.5 | 2,667.2 | 2,892.8 | 3,137.5 | 3,402.9 | 3,690.8 |
| EBIT, % | 17.15 | 16.71 | 14.39 | 7.42 | 7.86 | 12.71 | 12.71 | 12.71 | 12.71 | 12.71 |
| Total Cash | 7,260.5 | 5,369.2 | 4,422.4 | 3,920.0 | 3,941.9 | 6,263.2 | 6,793.0 | 7,367.6 | 7,990.8 | 8,666.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,147.0 | 4,862.7 | 8,910.7 | 8,138.4 | 9,795.7 | 8,354.7 | 9,061.4 | 9,827.9 | 10,659.2 | 11,560.8 |
| Account Receivables, % | 20.57 | 30.75 | 43.79 | 53.27 | 50.61 | 39.8 | 39.8 | 39.8 | 39.8 | 39.8 |
| Inventories | 5,011.2 | 5,242.7 | 5,386.2 | 6,451.1 | 6,364.8 | 7,032.1 | 7,627.0 | 8,272.1 | 8,971.9 | 9,730.8 |
| Inventories, % | 32.76 | 33.15 | 26.47 | 42.22 | 32.88 | 33.5 | 33.5 | 33.5 | 33.5 | 33.5 |
| Accounts Payable | 2,656.3 | 2,097.9 | 2,071.5 | 2,017.6 | 2,929.4 | 2,903.4 | 3,149.0 | 3,415.3 | 3,704.2 | 4,017.6 |
| Accounts Payable, % | 17.37 | 13.27 | 10.18 | 13.21 | 15.13 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 |
| Capital Expenditure | -1,253.2 | -1,337.7 | -936.9 | -563.2 | -521.9 | -1,160.4 | -1,258.6 | -1,365.0 | -1,480.5 | -1,605.7 |
| Capital Expenditure, % | -8.19 | -8.46 | -4.6 | -3.69 | -2.7 | -5.53 | -5.53 | -5.53 | -5.53 | -5.53 |
| Tax Rate, % | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 | -4.95 |
| EBITAT | 1,933.2 | 1,971.4 | 2,246.3 | 1,031.0 | 1,595.8 | 2,219.0 | 2,406.7 | 2,610.3 | 2,831.1 | 3,070.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4,190.8 | -1,141.2 | -2,001.1 | 1,295.6 | 1,625.2 | 2,946.0 | 1,328.3 | 1,440.6 | 1,562.5 | 1,694.7 |
| WACC, % | 5.7 | 5.71 | 5.74 | 5.95 | 6.08 | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 7,706.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,729 | |||||||||
| Terminal Value | 45,058 | |||||||||
| Present Terminal Value | 33,931 | |||||||||
| Enterprise Value | 41,637 | |||||||||
| Net Debt | 2,289 | |||||||||
| Equity Value | 39,349 | |||||||||
| Diluted Shares Outstanding, MM | 5,036 | |||||||||
| Equity Value Per Share | 7.81 |
Benefits of Choosing [0570HK]
- Pre-Filled Financial Model: Leverage China Traditional Chinese Medicine's actual data for accurate DCF valuation.
- Comprehensive Forecast Management: Easily modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Instant updates allow you to view results immediately as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for high-level valuation presentations.
- Flexible and Reusable: Designed with adaptability in mind for ongoing detailed forecasts.
Key Features
- Real-Time 0570HK Data: Includes historical financial information and future projections for China Traditional Chinese Medicine Holdings Co. Limited.
- Customizable Assumptions: Modify inputs such as revenue growth, profit margins, WACC, tax rates, and capital investments.
- Interactive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Generate various forecasting scenarios to evaluate different potential valuation results.
- User-Centric Interface: Designed to be intuitive and accessible for both industry professionals and novices.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled data for China Traditional Chinese Medicine Holdings Co. Limited (0570HK) (historical and projected).
- Step 3: Modify key assumptions (yellow cells) based on your analysis.
- Step 4: Observe automatic recalculations for the intrinsic value of China Traditional Chinese Medicine Holdings Co. Limited (0570HK).
- Step 5: Utilize the results for investment decisions or reporting.
Why Opt for This Calculator?
- Precise Data: Authentic financial metrics from China Traditional Chinese Medicine Holdings Co. Limited (0570HK) guarantee dependable valuation outcomes.
- Fully Customizable: Tailor essential variables such as growth rates, WACC, and tax rates to align with your forecasts.
- Efficient: Built-in calculations streamline the process, so you don't have to start from the ground up.
- Expert-Level Tool: Crafted for investors, analysts, and consultants in the industry.
- Easy to Use: User-friendly design and guided instructions make it accessible for everyone.
Who Should Consider This Product?
- Individual Investors: Gain insights to make educated decisions regarding the purchase or sale of China Traditional Chinese Medicine Holdings Co. Limited (0570HK) stock.
- Financial Analysts: Enhance your valuation methods with readily available financial models tailored for the industry.
- Consultants: Provide accurate and timely valuation insights for clients focused on traditional Chinese medicine.
- Business Owners: Learn how large entities like China Traditional Chinese Medicine Holdings Co. Limited (0570HK) are valued to inform your own business strategies.
- Finance Students: Explore valuation strategies using practical data and scenarios specific to the sector.
Contents of the Template
- Comprehensive DCF Model: An editable template designed with detailed valuation calculations.
- Real-World Data: Historical and projected financials of China Traditional Chinese Medicine Holdings Co. Limited (0570HK) preloaded for your analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Embedded analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visual representations through charts and tables for clear, actionable findings.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.